WelbyTSE:4438 +2.43%36 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates TSE:4438 with a GF Score™ of 36/100 and a GF Value™ of 円378.19 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Welby ranks better than 69.36% on this metric.
The historical rank and industry rank for Welby's Days Payable or its related term are showing as below:
TSE:4438'
s Days Payable Range Over the Past 10 Years
Min: 56.46 Med: 75.3 Max: 114.93
Current: 99.61
During the past 10 years, Welby's highest Days Payable was 114.93. The lowest was 56.46. And the median was 75.30.
TSE:4438's Days Payable is ranked better than 69.36% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 57.13
vs TSE:4438: 99.61
Welby's Days Payable
stayed the same
from Dec. 2024 (0.00) to Dec. 2025 (0.00).
stayed the same
Welby Days Payable Related Terms
Welby Days Payable Historical Data
* Premium members only.
The historical data trend for Welby's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4438 vs VEEV, BTSG, TEM: Days Payable Comparison
For the Health Information Services subindustry, Welby's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Welby Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Welby's Days Payable distribution charts can be found below:
* The bar in red indicates where Welby's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Welby's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Welby (TSE:4438) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Welby and its competitors. Over the past decade, Welby's Days Payable has ranged from 56.46 to 114.93. According to the industry distribution chart, Welby ranks #186 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 30.6%.
Is Welby's Days Payable too high?
Welby's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 56.46 to a high of 114.93. Based on the distribution chart, Welby ranks #186 out of 607 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Welby has a GF Score™ of 36/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Welby's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Welby ranks #186 out of 607 companies for Days Payable. This puts Welby in the upper half of its industry. The industry median Days Payable is 57.13. Historically, Welby's own Days Payable has ranged from 56.46 to 114.93 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.13, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Welby and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Welby's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welby stock overvalued right now?
Based on GuruFocus' analysis, Welby (TSE:4438) is currently considered Possible Value Trap. The stock's GF Value™ is 円378.19, compared to a current price of 円253.00 — trading 33.1% below its estimated fair value. The current Days Payable is 0.00. Welby's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Welby (TSE:4438), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Welby (TSE:4438) Overvalued in 2026?
Based on GuruFocus' analysis, Welby stock appears to be undervalued.
The current stock price of 円253.00 is trading 33.1% below its estimated GF Value™ of 円378.19.
GuruFocus considers Welby to be Possible Value Trap.
Key valuation signals for TSE:4438:
Days Payable: 0.00
GF Value™: 円378.19 vs. price of 円253.00 (33.1% below fair value)
No single metric tells the full story. See the TSE:4438 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Welby Inc offers patients and their families digital tools helping medical treatment and prevention of the progression of disease. The company co-develops and co-provides digital services with pharmaceuticals, medical device companies, governments, along with patients and healthcare professionals.
36GF Score
Get the complete analysis for TSE:4438
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4438 has been successfully added to your 
